Ocugen (OCGN) Announces Positive Preliminary Safety and Efficacy Results from the Phase 1/2 Trial of OCU400 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Favorable safety and tolerability profile related to OCU400 investigational product candidateInitial clinical data from low and medium dose cohorts indicates positive trend in Multi-luminance mobility. | April 14, 2023